ArticlePloS one2020

An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications.

Yihui Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.